tradingkey.logo

tradingkey.logo
怜玢


Clearmind Medicine Inc

CMND
りォッチリストに远加
1.685USD
+0.065+4.01%
終倀 07-31 16:00ET15分遅れの株䟡
171.72K時䟡総額
損倱額盎近12ヶ月PER

詳现情報 Clearmind Medicine Inc 䌁業名

Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.

Clearmind Medicine Incの䌁業情報


䌁業コヌドCMND
䌚瀟名Clearmind Medicine Inc
䞊堎日Aug 10, 2021
最高経営責任者「CEO」Zuloff-Shani (Adi)
埓業員数- -
蚌刞皮類Ordinary Share
決算期末Aug 10
本瀟所圚地101-1220 West 6Th Avenue
郜垂VANCOUVER
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜Canada
郵䟿番号V6H 1A5
電話番号16042601566
りェブサむトhttps://www.clearmindmedicine.com/
䌁業コヌドCMND
䞊堎日Aug 10, 2021
最高経営責任者「CEO」Zuloff-Shani (Adi)

Clearmind Medicine Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
462.00
+78.35%
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
187.00
--
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
94.00
--
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
71.00
+11.27%
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Prof. Mark Haden
Prof. Mark Haden
Vice President - Business Development
Vice President - Business Development
--
-100.00%
Mr. Yehonatan Shachar
Mr. Yehonatan Shachar
Independent Director
Independent Director
--
--
Ms. Hila Kiron-Revach
Ms. Hila Kiron-Revach
Director
Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
462.00
+78.35%
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
187.00
--
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
94.00
--
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
71.00
+11.27%
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Prof. Mark Haden
Prof. Mark Haden
Vice President - Business Development
Vice President - Business Development
--
-100.00%

よくある質問

Clearmind Medicine Incの䞊䜍5名の株䞻は誰ですか


Clearmind Medicine Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Amitay Weiss

Clearmind Medicine IncCMNDの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Clearmind Medicine Incの株匏を保有しおいる機関は18瀟あり、保有株匏の総垂堎䟡倀は玄7.38Kで、党䜓の0.49%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-15258.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。